ELV
Elevance Health, Inc.
- EBITDA, 2025
- $8.7B
- YoY, 2025
- −5.5%
- 5-year CAGR
- +3.1%
- 10-year CAGR
- +4.4%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $8.7B | −5.5% |
| 2024 | $9.3B | −9.7% |
| 2023 | $10.2B | +2.9% |
| 2022 | $10.0B | +12.4% |
| 2021 | $8.9B | +17.9% |
| 2020 | $7.5B | +5.4% |
| 2019 | $7.1B | +8.8% |
| 2018 | $6.6B | +29.5% |
| 2017 | $5.1B | −11.3% |
| 2016 | $5.7B | +0.9% |
| 2015 | $5.7B | +7.4% |
| 2014 | $5.3B | +7.3% |
| 2013 | $4.9B | +12.6% |
| 2012 | $4.4B | −1.3% |
| 2011 | $4.4B | −5.5% |
| 2010 | $4.7B | −1.2% |
| 2009 | $4.7B | −3.8% |
| 2008 | $4.9B | — |